Invesco Ltd. - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,364,001
-64.6%
62,441
-63.6%
0.00%
-66.7%
Q2 2023$12,329,163
+230.2%
171,572
+183.5%
0.00%
+200.0%
Q1 2023$3,733,305
-65.3%
60,527
-56.6%
0.00%
-66.7%
Q4 2022$10,756,472
+40.9%
139,459
-18.5%
0.00%
+50.0%
Q3 2022$7,632,000
+1527.3%
171,050
+1298.7%
0.00%
Q2 2022$469,000
-9.1%
12,229
-1.9%
0.00%
Q1 2022$516,000
+10.0%
12,469
+0.5%
0.00%
Q4 2021$469,000
+4.7%
12,413
-8.8%
0.00%
Q3 2021$448,000
-96.0%
13,605
-91.7%
0.00%
-100.0%
Q2 2021$11,089,000
+48.2%
164,383
+24.4%
0.00%
+50.0%
Q1 2021$7,481,000
-77.0%
132,133
-66.9%
0.00%
-77.8%
Q4 2020$32,514,000
+6.8%
399,092
-6.6%
0.01%
-10.0%
Q3 2020$30,458,000
-25.8%
427,488
-14.3%
0.01%
-33.3%
Q2 2020$41,028,000
+6.0%
498,639
-24.2%
0.02%
-6.2%
Q1 2020$38,723,000
-38.7%
658,222
+7.7%
0.02%
-20.0%
Q4 2019$63,190,000
+228.9%
611,359
-35.6%
0.02%
+300.0%
Q3 2019$19,214,000
-7.6%
949,305
+17.6%
0.01%0.0%
Q2 2019$20,793,000
+39.1%
807,509
-23.1%
0.01%0.0%
Q1 2019$14,948,0001,050,4780.01%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders